Related Experiment Videos
Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells
Hong Li1,2, Houbo Jiang1,2, Boyang Zhang1,2
1Veterans Affairs Western New York Healthcare System, Buffalo, NY, USA.
Journal of Parkinson'S Disease
|August 29, 2018
Summary
Induced pluripotent stem cells (iPSCs) enable the creation of patient-specific neurons to model Parkinson's disease (PD). This approach aids in understanding disease mechanisms and discovering new drugs for neurodegenerative disorders.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Parkinson's disease (PD) is the second leading neurodegenerative disorder, marked by the loss of dopaminergic (DA) neurons.
- Most PD cases are idiopathic, but gene mutations cause rare familial forms.
- Developing accurate animal models for PD remains a significant challenge.
Purpose of the Study:
- To review methods for generating induced pluripotent stem cells (iPSCs).
- To discuss studies utilizing iPSC-derived neurons from familial PD cases.
- To highlight the potential of patient-specific neurons in advancing PD research and drug discovery.
Main Methods:
- Generation of induced pluripotent stem cells (iPSCs).
- Derivation of patient-specific dopaminergic (DA) neurons from iPSCs.
- Analysis of iPSC-derived neurons from monogenic forms of Parkinson's disease (PD).
Main Results:
- iPSC technology allows for the generation of patient-specific DA neurons.
- Studies using iPSC-derived neurons reveal converging pathways implicated in PD.
- These neurons exhibit vulnerabilities specific to human nigral DA neurons.
Conclusions:
- Patient-specific neurons derived from iPSCs offer a powerful tool for studying PD mechanisms.
- Advancements in stem cell biology and genome editing (isogenic iPSCs) enhance the utility of these models.
- iPSC-derived neurons are poised to transform Parkinson's disease research and facilitate drug discovery.